NEW! Bi-Valent COVID-19 Booster
The Federal Drug Administration (FDA) has approved a new COVID-19 booster (bi-valent) that targets both the Delta and Omicron strains. This new vaccine replaces all prior booster recommendations for ages 12+. If you have an appointment for a booster, make sure the newest version will be delivered, or schedule a new appointment.
The new booster dose is administered at least 2 months after completion of the primary series. For people who previously received a monovalent booster dose(s), the bivalent booster dose is administered at least 2 months after the last monovalent booster dose.
- Ages 12+ - Bivalent Pfizer booster delivered at least 2 months after completion of primary series.
- Ages 18+ -Bivalent Moderna or Pfizer booster dose Delivered at least 2 months after completion of primary series
- Children ages 5-11 who received a Pfizer vaccine in their primary series are ONLY eligible for a monovalent (original) Pfizer booster dose 5 months after their second vaccine. Currently children in this age group who received a Moderna vaccine in their primary series are not eligible for a booster of any kind.
Anyone 6 months of age and older is eligible for a vaccine.